Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
MOMENTA PHARMACEUTICALS INC (0001235010)
Standardized SEC financial data for MOMENTA PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001235010 · Biological Products, (No Diagnostic Substances).
Operating margin
-387.8%
Net margin
-737.6%
Revenue growth (YoY)
-68.4%
Return on equity
-38.7%
Free cash flow
-$206.6M
Current ratio
5.08×
EPS (diluted)
$-2.13
Ratios for fiscal year 2019, standardized from SEC filings.